Gaughan, E., Quinn, T., Mills, A., Bruce, A., Antonelli, J., Mackinnon, A., Aslanis, V., Li, F., O'Connor, R., Boz, C., Mills, R., Emanuel, P., Burgess, M., Rinaldi, G., Valanciute, A., Mills, B., Scholefield, E., Hardisty, G., Gwyer Findlay, E., Parker, R., Norrie, J., Dear, J., Akram, A., Koch, O., Templeton, K., Dockrell, D., Walsh, T., Partridge, S., Humphries, D., Wang-jairaj, J., Slack, R., Schambye, H., Phung, D., Gravelle, L., Lindmark, B., Shankar-Hari, M., Hirani, N., Sethi, T. & Dhaliwal, K. 2022, 'An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis (DEFINE): A Phase Ib/IIa Randomised Controlled Trial', American Journal of Respiratory and Critical Care Medicine, 207(2). https://doi.org/10.1164/rccm.202203-0477OC